Dextran 70: Difference between revisions
Jump to navigation
Jump to search
imported>Howard C. Berkowitz (New article generated using Special:MetadataForm) |
mNo edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
'''Dextran 70''' is a glucose polymer used medically as a colloid, injected intravenously, to increase the [[human blood plasma|plasma]] volume in [[hypovolemia]]. The number comes from its average molecular weight of approximately 70,000. Dextrans, which principally have 1,6-glucosidic linkages, have molecular weights ranging from 20,000 to 200,000. | |||
Dextran is similar in application to [[hydroxyethyl starch]], but is more antigenic. Neither has oxygen-carrying capacity, or contributes to the ability of blood to coagulate. | |||
It is cheaper than hydroxyethyl starch and [[albumin injection]].[[Category:Suggestion Bot Tag]] | |||
Latest revision as of 16:00, 6 August 2024
Dextran 70 is a glucose polymer used medically as a colloid, injected intravenously, to increase the plasma volume in hypovolemia. The number comes from its average molecular weight of approximately 70,000. Dextrans, which principally have 1,6-glucosidic linkages, have molecular weights ranging from 20,000 to 200,000.
Dextran is similar in application to hydroxyethyl starch, but is more antigenic. Neither has oxygen-carrying capacity, or contributes to the ability of blood to coagulate.
It is cheaper than hydroxyethyl starch and albumin injection.